Last reviewed · How we verify
RNA seq analysis
At a glance
| Generic name | RNA seq analysis |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Effects of 5G Radiation on Skin (NA)
- Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.
- An Exosomal miRNA-based Liquid Biopsy for ICC Detection
- Prospective Study for the Prognostic and Predictive Role of Circulating Tumor Cells in Patients With Oropharyngeal Squamous Cell Carcinoma: CTCO (Circulating Tumor Cells in the Oropharynx)
- Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity (NA)
- Respiratory Microbiota and Immune Response in CVID
- ARTEMIS - The ARTEMIS Cohort
- Genomic Profiling in Cancer Patients
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- RNA seq analysis CI brief — competitive landscape report
- RNA seq analysis updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI